SKIN FIBROSIS

This adverse event was reported 484 times

These drugs are most commonly taken by patients reporting SKIN FIBROSIS:

# Drug Count
0 GADODIAMIDE 208
1 GADOBENATE DIMEGLUMINE 145
2 GADOTERIDOL 112
3 EPOETIN ALFA 102
4 PREDNISONE 74
5 ASPIRIN 58
6 FUROSEMIDE 58
7 METOPROLOL TARTRATE 57
8 AMLODIPINE BESYLATE 56
9 ASPIRIN 325 MG 56
See all common drugs associated with SKIN FIBROSIS

SKIN FIBROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GADODIAMIDE 208 0.0619
1 GADOTERIDOL 112 0.0617
2 GADOBENATE DIMEGLUMINE 145 0.0329
3 COBALT 1 0.0256
4 DOXERCALCIFEROL 2 0.0120
5 EPOETIN ALFA 102 0.0086
6 FERROUS ASPARTO GLYCINATE, IRON, ASCORBIC ACID, FOLIC ACID, CYANOCOBALAMIN, ZINC, AND SUCCINIC ACID 4 0.0066
7 DIFLORASONE DIACETATE 1 0.0052
8 SODIUM FERRIC GLUCONATE COMPLEX 11 0.0051
9 PRAMOXINE HYDROCHLORIDE, MENTHOL 1 0.0047
See all drugs enriched for association with SKIN FIBROSIS

SKIN FIBROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Paramagnetic Contrast Agent [EPC] 208 0.0452
1 Vitamin D2 Analog [EPC] 37 0.0052
2 Vitamin D Analog [EPC] 37 0.0021
3 Parenteral Iron Replacement [EPC] 22 0.0016
4 Vitamin D3 Analog [EPC] 28 0.0014
5 Calcitonin [EPC] 4 0.0013
6 Gadolinium-based Contrast Agent [EPC] 6 0.0012
7 Blood Viscosity Reducer [EPC] 5 0.0012
8 Erythropoiesis-stimulating Agent [EPC] 44 0.0008
9 Lymphocyte Growth Factor [EPC] 1 0.0008
See all drug classes enriched for association with SKIN FIBROSIS